Cargando…
Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes
Lentiviral vectors (LVs) are excellent tools for gene transfer into mammalian cells. It is noteworthy that the first gene therapy treatment using LVs was approved for commercialization in 2017. The G glycoprotein from rhabdovirus vesicular stomatitis virus (VSV-G) is the glycoprotein most used to ps...
Autores principales: | Tomás, Hélio A., Mestre, Daniel A., Rodrigues, Ana F., Guerreiro, Miguel R., Carrondo, Manuel J.T., Coroadinha, Ana Sofia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742969/ https://www.ncbi.nlm.nih.gov/pubmed/31528654 http://dx.doi.org/10.1016/j.omtm.2019.08.001 |
Ejemplares similares
-
Vpu-dependent block to incorporation of GaLV Env into lentiviral vectors
por: Christodoulopoulos, Ilias, et al.
Publicado: (2010) -
The stability of envelope-pseudotyped lentiviral vectors
por: Dautzenberg, Iris J. C., et al.
Publicado: (2020) -
βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin
por: Song, Yul Eum, et al.
Publicado: (2018) -
Efficient Pseudotyping of Different Retroviral Vectors Using a Novel, Codon-Optimized Gene for Chimeric GALV Envelope
por: Mirow, Manuela, et al.
Publicado: (2021) -
Pseudotyping Lentiviral Vectors: When the Clothes Make the Virus
por: Duvergé, Alexis, et al.
Publicado: (2020)